SamanTree Medical Reports 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at 2024 SABCS

SamanTree Medical, a leader in oncologic surgical imaging innovation, announced promising results from the SHIELD study, to be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS) on Dec. 12. The findings reveal that the Histolog® Scanner, a confocal…

Read MoreSamanTree Medical Reports 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at 2024 SABCS

Syncell Announces $15 Million Series A to Boost Global Growth of Protein Purification and Spatial Proteomics Tech

Syncell, a leader in advanced subcellular protein purification and spatial proteomics analysis, has successfully closed a $15 million Series A funding round, bringing its total funding to $30 million. The capital will be used to drive the global commercialization and…

Read MoreSyncell Announces $15 Million Series A to Boost Global Growth of Protein Purification and Spatial Proteomics Tech

RevBio Gets FDA Approval to Expand Trial and CMS Reimbursement for Regenerative Bone Adhesive

RevBio, Inc. announced that it has received FDA approval to expand its ongoing clinical trial to use TETRANITE®, its bone adhesive biomaterial, for immediate cranial flap fixation. Additionally, the company has secured reimbursement coverage from the Centers for Medicare and…

Read MoreRevBio Gets FDA Approval to Expand Trial and CMS Reimbursement for Regenerative Bone Adhesive

Protaryx Medical Completes First-in-Human Study of Innovative Transseptal Puncture Technology

Protaryx Medical, a leader in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study for its groundbreaking transseptal puncture technology. The study, conducted on December 3, 2024, at Sanatorio Italiano de Asunción in Paraguay,…

Read MoreProtaryx Medical Completes First-in-Human Study of Innovative Transseptal Puncture Technology

Alpha Cognition Reports Positive Interim Data for ALPHA-1062 in Military Traumatic Brain Injury Model

Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG), a biopharmaceutical company focused on developing innovative therapies for neurodegenerative disorders, today announced promising interim preclinical data supporting the ongoing development of ALPHA-1062 for the treatment of mild traumatic brain injury (mTBI). The…

Read MoreAlpha Cognition Reports Positive Interim Data for ALPHA-1062 in Military Traumatic Brain Injury Model

Menarini Group and MEDSIR Unveil Phase III ADELA Study: New Therapy for Advanced Breast Cancer

The Menarini Group, a global leader in pharmaceuticals and diagnostics, and its subsidiary Stemline Therapeutics, focused on delivering innovative oncology treatments, have partnered with MEDSIR, a top independent clinical research organization in oncology and part of Oncoclínicas & Co., the…

Read MoreMenarini Group and MEDSIR Unveil Phase III ADELA Study: New Therapy for Advanced Breast Cancer

Sol-Millennium® Receives Positive Feedback on Needle-Free Insulin Device in Canada

Sol-Millennium® Medical Group, a leading medical device manufacturer, has introduced an innovative needle-free insulin injection device that has garnered widespread acclaim in Canada. This groundbreaking technology aims to enhance the lives of millions of people with diabetes by eliminating the…

Read MoreSol-Millennium® Receives Positive Feedback on Needle-Free Insulin Device in Canada